Serotonin (5-HT) stimulated the release of arachidonic acid in hippocampal neurons cocultured with glial cells but not in glial cultures alone. Similar results were observed for the 5-HT-stimulated release of inositol phosphates. These results suggest a neural but not glial orign of both responses.
[3UHcholine-labeled cells with no increase in the release of [3HUcholine or phospho[3Ulcholine. These data suggest that 5-UT stimulated the release of arachidonic acid in hippocampal neurons through the activation of phospholipase A2, independent of the activation of phospholipase C.
The excitable membranes of the central nervous system are enriched in 20-carbon unsaturated fatty acids, particularly arachidonic acid (1) . Arachidonic acid serves as a precursor to a number of biologically active acid lipids, including prostaglandins, leukotrienes, and thromboxanes. Arachidonic acid and its eicosanoid metabolites are released after activation ofcertain neurotransmitter receptors and may play a role in neurotransmission. Recent studies have demonstrated (2-4) receptor-mediated release of eicosanoids in brain cells in primary culture. N-Methyl-D-aspartate stimulated the release of arachidonic acid, 11-HETE, and 12-HETE (where HETE is hydroxyeicosatetraenoic acid) in striatal cells (2) as well as arachidonic acid in cerebellar granule cells (3) . Bradykinin stimulated arachidonic acid mobilization from dorsal root ganglion neurons (4). It is not clear from these studies whether the release of arachidonic acid is independent of inositolphospholipid turnover and whether the response is neural or glial in origin. Recent studies demonstrated a-adrenergic receptor stimulation caused arachidonic acid release from spinal cord, hippocampal, and cortical neurons, but not from glia cells, grown in primary culture that was independent of inositolphospholipid turnover (5) .
Central serotonin (5-HT) receptors are involved in sleep, depression, hallucinations, anxiety, sexual behavior, memory, appetite control, and thermoregulation (6) . 5-HT receptors exist as several subtypes and transduce their signals by way of multiple intracellular messengers (7) . Types 1A, 1B, and 1D 5-HT receptors (5-HT1A, 5-HT1B, and 5-HTlD) modulate adenylate cyclase activity and types 1C and 2 5-HT (5-HT1c and 5-HT2) receptors increase inositolphospholipid turnover. The mechanism of signal transduction for 5-HT type 3 (5-HT3) receptors is presently unknown. 5-HT-stimulated prostaglandin production has been suggested in rat brain homogenates (8) , but these studies did not address the cell type involved in the response and a single large dose (500 ,uM) was used and, therefore, could be nonspecific. 5-HT-stimulated release of prostacyclin was observed in bovine smooth muscle cells, but the response was not assigned to a 5-HT receptor subtype (9) . In this study, we demonstrate that 5-HT stimulates the release of arachidonic acid in hippocampal neurons but not glial cells through a 5-HT2
receptor. The release of arachidonic acid appears to be mediated through activation of phospholipase A2 and is independent of inositolphospholipid turnover.
MATERIALS AND METHODS Materials. [5,6,8,9,11,12,14,15- Cell Culture. Hippocampal glial cultures were established from whole hippocampus from 17-day gestational C57BL/6J mouse embryos as described (10) except that cultures were plated on Nunclon multidish (Rosklide, Denmark) 24-well plates. Hippocampal neural/glial cocultures were plated over confluent glial cell beds and were maintained identically as glial cultures except that 5% (vol/vol) horse serum was substituted for 10o (vol/vol) fetal calf serum in the growth medium. The cells were used for biochemical assays between Abbreviations: 5-HT, serotonin; 5-HT1A receptor, 5-HT2 receptor, etc., type 1A 5-HT receptor, type 2 5-HT receptor, etc.; PMA, phorbol 12-myristate 13-acetate; DOI, (R)-(-)-2,5-dimethoxy-4-iodo-phenylisopropylamine; TFMPP, m-trifluoromethylphenylpiperazine; 8-OH DPAT, 8-hydroxy-2-(di-n-propylamino)tetralin; MCPP, m-chlorophenylpiperazine; HETE, hydroxyeicosatetraenoic acid.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. effect on 5-HT-stimulated arachidonic acid release (Fig. 4A) . Similar results were seen for the release of inositol phosphates (data not shown). failed to stimulate the release of arachidonic acid. Isoproterenol, a p-adrenergic receptor agonist, slightly increased the release of arachidonic acid. Similar results were seen for the release of inositol phosphates (data not shown). These data suggest that the release of arachidonic acid and inositol phosphates was due to the stimulation of a 5-HT2 receptor.
5-HT receptor subtype was further established using the 5-HT2 receptor antagonists spiperone (22, 23) , ketanserin (24, 25) , and m-chlorophenylpiperazine (MCPP) (19) (Fig. 5) . Both spiperone and ketanserin were potent antagonists for respectively. Spiperone, ketanserin, and MCPP had no effect on the release of arachidonic acid when added alone up to 10 ,uM (data not shown). MCPP alone weakly stimulated the release of inositol phosphates at concentrations above 100 nM (EC50 = 10 ,uM) with a maximal 50% increase over basal stimulation at 100 IM. MCPP blocked 5-HT-stimulated release of inositol phosphates 50% at 100 ,uM (data not shown). (17) . Ketanserin and spiperone, potent 5-HT2 antagonists, blocked both responses at low nanomolar concentrations. These data suggest 5-HT2 receptors mediate the release of both arachidonic acid and inositol phosphates.
5-HT-Stimulated
The presence oftwo subtypes ofthe 5-HT2 receptor, 5-HT2A and 5-HT2B, has been suggested based on binding studies with the agonist DOI (18) . In contrast, shifts in binding curves upon addition of nucleotides suggested that multiple 5-HT2 receptor sites are actually high-and low-affinity forms of the same receptor (28) . In these studies, both release ofarachidonic acid and inositol phosphates were weakly stimulated by DOI (EC50 = 10 ,uM for both). It is not apparent from these limited studies the nature of the 5-HT2 receptor involved in the release of arachidonic acid. More insight will be possible through the study of the expressed 5-HT2 receptor in a host cell devoid of endogenous 5-HT receptors.
A correlation exists between 5-HT2 receptor localization and 5-HT-stimulated release of arachidonic acid. 5-HT2 receptors have been localized in regions of the hippocampus and cerebral cortex (27) where 5-HT stimulated the release of arachidonic acid from neurons. We were unable to detect 5-HT-stimulated release of arachidonic acid in cerebellum, spinal cord, and striatum, where very low levels of receptors have been measured (27) .
Several metabolic pathways exist for the receptormediated generation of arachidonic acid from membrane phospholipids. Previous studies have shown that phosphatidylcholine, phosphatidylserine, and phosphatidylinositol are rich in arachidonic acid in the second position of their glycerol backbone, making them good candidates as substrates for hormone regulated phospholipases. Predominantly phosphatidylcholine and phosphatidylinositol are labeled with added arachidonic acid in brain tissue (29) . Phospholipase A2 can hydrolyze phosphatidylcholine directly to release free arachidonic acid and yield lysophosphatidylcholine. Indeed, 5-HT stimulated the release of arachidonic acid and lysophosphatidylcholine that was blocked by the addition of the 5-HT2 antagonist spiperone in hippocampal neurons. The 5-HT-stimulated release of arachidonic acid was dependent on extracellular calcium, a characteristic of phospholipase A2 (26) .
The addition of the phorbol ester PMA inhibited 5-HT-stimulated release of inositol phosphates coincident with enhancement of 5-HT-stimulated arachidonic acid release; therefore, it is unlikely that inositolphospholipid-specific phospholipase C is involved in the generation of arachidonic acid. Arachidonic acid could also be generated by the hydrolysis of diacylglycerol by diglyceride lipase, with diacylglycerol originating from the action of phospholipase C on phosphatidylcholine (15) . It is also conceivable that arachidonic acid could arise from receptor-mediated activation of phosphatidylcholine-specific phospholipase D to yield phosphatidic acid. Arachidonic acid would then be liberated by the action of diglyceride lipase on phosphatidic acid. These two pathways do not appear to play a major role in the generation of arachidonic acid in the hippocampal neuron since there was no detectable increase in the release of phospho[3Hlcholine or [3H]choline from [3H]choline-labeled cells. Furthermore, 5-HT-receptor-mediated release of arachidonic acid was totally dependent on extracellular calcium, a characteristic not associated with either phospholipase C or D (30) (31) (32) . In addition, the diglyceride lipase inhibitor, RHC 80267, did not block 5-HT-stimulated release of arachidonic acid.
Recent evidence has suggested that receptors are coupled to phospholipase A2 through aguanine nucleotide binding protein (33) . Receptor-mediated activation ofphospholipase A2 can be both pertussis toxin-sensitive (34) and -insensitive (35) . Pertussis toxin binds to and inactivates certain guanine nucleotide binding proteins by catalyzing ADP-ribosylation of their a subunits. In our cells, neither 5-HT-stimulated release of arachidonic acid or inositol phosphates was sensitive to pertussis toxin when the neurons were exposed to 10 ng/ml for 18 hr (data not shown). Therefore, it is not clear if either of these two effector enzymes are linked to the 5-HT receptor through guanine nucleotide binding proteins in this system.
Analysis of the eicosanoids produced in hippocampal cultures demonstrated that several prostaglandins, leukotrienes, and small amounts of HETEs were produced under basal conditions. 5-HT stimulated a modest increase in all detected metabolites in cultures containing neurons but not in glial cultures. The physiologic role of 5-HT-receptor-stimulated release of arachidonic acid and subsequent eicosanoid formation in the hippocampus is not clear. Several other neurotransmitters have been shown to stimulate arachidonic acid mobilization in neurons, including norepinephrine, histamine, bradykinin, and glutamate (2) (3) (4) (5) 36) . Arachidonic acid and one of its lipoxygenase metabolites 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid can inhibit ion conductances and cause presynaptic inhibition ofneurotransmitter release (37) presumably through inhibition of Ca2+/ calmodulin-dependent protein kinase II, a protein thought to be involved in neurotransmitter release (38) . Arachidonic acid may also play a role in long-term potentiation (39) , may activate potassium channels in cardiac and smooth muscle cells (40, 41) , stimulates the release of intracellular calcium (42) , and stimulates protein kinase C (43) . Arachidonic acid and its eicosanoid metabolites have also been implicated in a number of pathophysiological processes, including trauma, hypoxia, ischemia, hypoglycemia, electroconvulsive shock, and fever (44) , and are released in brain during stroke and seizures (45) . 5-HT may potentially mediate some of these processes through receptor-generated arachidonic acid or eicosanoids.
